Inhibitors of Emerging Epigenetic Targets for Cancer Therapy: a Patent Review (2010–2014)
Year: 2015
Type: review
Source: Pharmaceutical Patent Analyst
DOI: 10.4155/ppa.15.16
Institutions: Harvard University, Dana-Farber Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2169347571